Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Cell Cycle. Found 43 abstracts

no pagination
Prudnikova TY, Villamar-Cruz O, Rawat SJ, Cai KQ, Chernoff J. Effects of p21-activated kinase 1 inhibition on 11q13-amplified ovarian cancer cells. Oncogene. 2016 Apr 28;35(17):2178-85.   PMCID: PMC5125076
Chakraborty AK, Mehra R, Digiovanna MP. Co-targeting ER and HER family receptors induces apoptosis in HER2-normal or overexpressing breast cancer models. Anticancer research. 2015 Mar;35(3):1243-50.
Plotnikova OV, Nikonova AS, Loskutov YV, Kozyulina PY, Pugacheva EN, Golemis EA. Calmodulin activation of Aurora-A kinase (AURKA) is required during ciliary disassembly and in mitosis. Mol Biol Cell. 2012 Jul;23(14):2658-70.   PMCID: PMC3395655
Sethi G, Pathak HB, Zhang H, Zhou Y, Einarson MB, Vathipadiekal V, Gunewardena S, Birrer MJ, Godwin AK. An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancer. PLoS One. 2012 Oct;7(10):e47086.   PMCID: 3467214
Ratushny V, Astsaturov I, Burtness BA, Golemis EA, Silverman JS. Targeting EGFR resistance networks in head and neck cancer. Cell Signal. 2009 Aug;21(8):1255-68.   PMCID: PMC2770888
Enders GH. Expanded roles for Chk1 in genome maintenance. The Journal of biological chemistry. 2008 Jun 27;283(26):17749-52.   PMCID: PMC2440615
Huang H, Fletcher L, Beeharry N, Daniel R, Kao G, Yen TJ, Muschel RJ. Abnormal cytokinesis after X-irradiation in tumor cells that override the G2 DNA damage checkpoint. Cancer Res. 2008 May 15;68(10):3724-32.
Plotnikova OV, Golemis EA, Pugacheva EN. Cell cycle-dependent ciliogenesis and cancer. Cancer Res. 2008 Apr;68(7):2058-61.   PMCID: PMC2546565
Ariazi EA, Leitao A, Oprea TI, Chen B, Louis T, Bertucci AM, Sharma CG, Gill SD, Kim HR, Shupp HA, Pyle JR, Madrack A, Donato AL, Cheng D, Paige JR, Jordan VC. Exemestane's 17-hydroxylated metabolite exerts biological effects as an androgen. Mol Cancer Ther. 2007 Nov;6(11):2817-27.
Zhang R, Chen W, Adams PD. Molecular dissection of formation of senescence-associated heterochromatin foci. Mol Cell Biol. 2007 Mar;27(6):2343-58.
Pugacheva EN, Roegiers F, Golemis EA. Interdependence of cell attachment and cell cycle signaling. Current opinion in cell biology. 2006 Oct;18(5):507-15.
Zhang R, Poustovoitov MV, Ye X, Santos HA, Chen W, Daganzo SM, Erzberger JP, Serebriiskii IG, Canutescu AA, Dunbrack RL, Pehrson JR, Berger JM, Kaufman PD, Adams PD. Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Developmental Cell. 2005 Jan;8(1):19-30.
Badawi AF, Eldeen MB, Liu Y, Ross EA, Badr MZ. Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma. Cancer Research. 2004 Feb;64(3):1181-9.
He J, Xu J, Xu XX, Hall RA. Cell cycle-dependent phosphorylation of Disabled-2 by cdc2. Oncogene. 2003 Jul 17;22(29):4524-30.
Chaturvedi P, Sudakin V, Bobiak ML, Fisher PW, Mattern MR, Jablonski SA, Hurle MR, Zhu Y, Yen TJ, Zhou BB. Chfr regulates a mitotic stress pathway through its RING-finger domain with ubiquitin ligase activity. Cancer Res. 2002 Mar 15;62(6):1797-801.
Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. The Journal of biological chemistry. 2002 Feb;277(5):3247-57.
Kandel ES, Skeen J, Majewski N, Di Cristofano A, Pandolfi PP, Feliciano CS, Gartel A, Hay N. Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage. Mol Cell Biol. 2002 Nov;22(22):7831-41.
Khare L, Astrinidis A, Senapedis W, Adams PD, Henske EP. Expression of wild type and mutant TSC2, but not TSC1, causes an increase in the G1 fraction of the cell cycle in HEK293 cells. J Med Genet. 2002 Sep;39(9):676-80.
Knudson AG. Cancer genetics. Am J Med Genet. 2002 Jul 22;111(1):96-102.
Ma J, Murphy M, O'Dwyer PJ, Berman E, Reed K, Gallo JM. Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance. Biochemical pharmacology. 2002 Apr;63(7):1219-28.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Cell Cycle

Cell Cycle metabolism genetics physiology Human Female US Gov't Support-PHS Apoptosis Cell Line Protein p53 Amino Acid Sequence Cultured Tumor Cells Non-US Gov't Support Signal Transduction Tumor Cell Line drug effects chemistry Molecular Sequence Data Mitosis Cell Cycle Proteins Mice Cell Proliferation Transcription Factors Mutation Transfection DNA Damage Neoplasm Proteins ph [Physiology] Neoplasms pathology Neoplastic Gene Expression Regulation Phosphorylation pharmacology Small Interfering RNA antagonists & inhibitors me [Metabolism] Non-Histone Chromosomal Proteins Mitotic Spindle Apparatus 0 (Transcription Factors) Cytokinesis Proteins RNA Interference Rats Proto-Oncogene Proteins c-bcl-2 de [Drug Effects] Biological Models Antineoplastic Agents Histones Animal Tumor Suppressor Genes Paclitaxel Cilia Recombinant Fusion Proteins DNA-Binding Proteins Molecular Models Reverse Transcriptase Polymerase Chain Reaction 0 (Neoplasm Proteins) aa [Analogs & Derivatives] Hela Cells Genetic Transcription Protein Binding Nuclear Proteins Centrosome Ovarian Neoplasms Breast Neoplasms pd [Pharmacology] Gene Expression Regulation Repressor Proteins DNA Repair drug therapy Chromatin Cyclins Cell Aging Heterochromatin bi [Biosynthesis] Estrogen Antagonists trastuzumab (Herceptin) Alkylating) 0 (Antineoplastic Agents Cytoplasmic and Nuclear) 0 (Receptors Phosphoprotein Phosphatase Enzyme Activation 0 (Cyclins) 0 (Nuclear Proteins) 0 (Repressor Proteins) Okadaic Acid Androgens fulvestrant (Faslodex) Adult 169590-42-5 (celecoxib) epidemiology Western Blotting 684-93-5 (Methylnitrosourea) Genotype CDC2 Protein Kinase 33069-62-4 (Paclitaxel) Fibroblasts 23214-92-8 (Doxorubicin) Cyclin-Dependent Kinases mammalian) 0 (MLH1 protein Androstadienes 4342-03-4 (Dacarbazine) Cell Cycle Checkpoints Non-US Gov't Research Support Calmodulin Hydroxylation Peptidylprolyl Isomerase Dosage Compensation (Genetics) 0 (macroH2A histone) Conserved Sequence Gamma Rays protein HP-1) Carcinogens Immunohistochemistry 35661-60-0 (N-(fluorenyl-9-methoxycarbonyl)leucine) Experimental Mammary Neoplasms 0 (Fluorenes) Dacarbazine ai [Antagonists & Inhibitors] estrogen receptor (ER) DNA Repair Enzymes Ionizing Radiation Dinoprostone deficiency Cell Adhesion 0 (15-deoxyprostaglandin J2) Oncogenes EC 3-6-1-3 (Adenosinetriphosphatase) Drug Interactions Carrier Proteins G2 Phase Calcineurin ras Proteins therapy Sprague-Dawley Rats biosynthesis human) 0 (ASF1A protein Phosphoproteins Cultured Cells EC 6-5-1 (DNA Repair Enzymes) Stress Isoenzymes ErbB-2 Receptor methods Adenosinetriphosphatase Epidermal Growth Factor Receptor 0 (Recombinant Fusion Proteins) Adenocarcinoma 0 (Isoenzymes) Her2 Cell Division
Last updated on Thursday, November 02, 2017